General Primary Care
News, opinions and meeting coverage in primary care.
<ѻýҕl>FDA Panel Puts Brakes on Anti-PARP Drugѻýҕl>
WASHINGTON -- Approval of a PARP inhibitor for patients with advanced ovarian cancer should await results of an ongoing clinical trial that has the potential to answer questions about the drug's safety and efficacy, according to an FDA advisory committee that voted against immediate approval.
Jun 25, 2014
<ѻýҕl>Orencia Combo Tops in Early, Severe RAѻýҕl>
PARIS -- In a study of patients with poor-prognosis early rheumatoid arthritis, more patients treated with abatacept (Orencia) plus methotrexate were in remission at 1 year than were those on methotrexate alone, a researcher reported here.
Jun 12, 2014